Carbamazepine ER

Generic: Carbamazepine

Labeler: Eywa Pharma Inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Active

Drug Facts

Product Profile

Brand Name Carbamazepine ER
Generic Name Carbamazepine
Labeler Eywa Pharma Inc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

CARBAMAZEPINE 400 mg/1

Identifiers & Regulatory

Product NDC 71930-074
Product ID 71930-074_fe788fd8-8083-4201-af83-010af795d108
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212948
Listing Expiration 2026-12-31
Marketing Start 2021-10-15

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71930074
Hyphenated Format 71930-074

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Carbamazepine ER (source: ndc)
Generic Name Carbamazepine (source: ndc)
Application Number ANDA212948 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-074-12)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-074-90)
source: ndc

Packages (2)

71930-074-12 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-074-12) 71930-074-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-074-90)

Ingredients (1)

CARBAMAZEPINE (400 mg/1)

Linked Drug Pages (1)

Carbamazepine ER ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fe788fd8-8083-4201-af83-010af795d108", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "upc": ["0371930074127", "0371930072123", "0371930073120"], "unii": ["33CM23913M"], "rxcui": ["199378", "402505", "402506"], "spl_set_id": ["48010b2b-526b-4bd6-87fd-87745c22cb8f"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Eywa Pharma Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-074-12)", "package_ndc": "71930-074-12", "marketing_start_date": "20211015"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-074-90)", "package_ndc": "71930-074-90", "marketing_start_date": "20211015"}], "brand_name": "Carbamazepine ER", "product_id": "71930-074_fe788fd8-8083-4201-af83-010af795d108", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "71930-074", "generic_name": "Carbamazepine", "labeler_name": "Eywa Pharma Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "brand_name_suffix": "ER", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "400 mg/1"}], "application_number": "ANDA212948", "marketing_category": "ANDA", "marketing_start_date": "20211015", "listing_expiration_date": "20261231"}